Success Metrics

Clinical Success Rate

100.0%

Based on 7 completed trials

Completion Rate

100%(7/7)

Active Trials

1(10%)

Results Posted

14%(1 trials)

Phase Distribution

Ph not_applicable

30%

Ph phase_3

20%

Ph phase_1

30%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 1Safety & dosage

3(37.5%)

Phase 3Large-scale testing

2(25.0%)

N/ANon-phased studies

3(37.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(7)

Terminated(1)

Other(1)

Detailed Status

Completed7

unknown1

Withdrawn1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 13 (37.5%)

Phase 32 (25.0%)

N/A3 (37.5%)

Trials by Status

unknown110%

withdrawn110%

recruiting110%

completed770%

Recent Activity

1 active trials

Showing 5 of 10

completedphase_1

Evaluation of Targeted Radionuclide Therapy of Lu-177 PSMA in Patients With Compromised Renal and/or Bone Marrow Function

NCT07169825

View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials

NCT05203497Phase 1

Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-ZHER2

Completed

NCT05923177Phase 1

Molecular Imaging of HER2 Expression in Breast Cancer Using [123I] I-(HE)3-G3

Completed

NCT03991260

99mTc-ADAPT6-based HER2 Imaging in Breast Cancer

Completed

NCT04277338Phase 1

Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-HE3-G3

Completed

NCT07169825Not Applicable

Evaluation of Targeted Radionuclide Therapy of Lu-177 PSMA in Patients With Compromised Renal and/or Bone Marrow Function

Recruiting

NCT04265209Phase 3

[18F] LBT-999 PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkinson's Diseases and Essential Tremor

Completed

NCT06028282

Post-RAI Therapy Dosimetry and Quality Assessment of Target Tissue Dosing

Unknown

NCT04139395Phase 3

68Ga Citrate PET/MRI for Evaluation of Fever of Unknown Origin (FUO)

Withdrawn

NCT01664858Not Applicable

Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease-2

Completed

NCT02264717Not Applicable

Dan-NICAD - Danish Study of Non-Invasive Diagnostic Testing in Coronary Artery Disease

Completed

All 10 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 10